Covered recipient · General Payments record
DARIA SCHATOFF
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2024–2025
$415.91
- Reported across 18 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $378.92 | 16 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $128.65 | 6 |
| Amneal Pharmaceuticals LLC | $80.80 | 3 |
| Insulet Corporation | $49.02 | 2 |
| ABBVIE INC. | $33.88 | 1 |
| Tandem Diabetes Care, Inc. | $27.93 | 1 |
| Amgen Inc. | $22.70 | 1 |
| GlaxoSmithKline, LLC. | $18.40 | 1 |
| Lilly USA, LLC | $17.54 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (16)
Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $33.88 | 09/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204094803 | CMS |
| Amgen Inc. | $22.70 | 06/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228577069 | CMS |
| Amneal Pharmaceuticals LLC | $26.96 | 02/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1220548576 | CMS |
| Amneal Pharmaceuticals LLC | $28.39 | 03/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1220548578 | CMS |
| Amneal Pharmaceuticals LLC | $25.45 | 06/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1220548580 | CMS |
| GlaxoSmithKline, LLC. | $18.40 | 05/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1191627152 | CMS |
| Insulet Corporation | $23.01 | 01/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207065055 | CMS |
| Insulet Corporation | $26.01 | 01/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207136623 | CMS |
| Lilly USA, LLC | $17.54 | 06/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186622130 | CMS |
| Novo Nordisk Inc | $18.46 | 02/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188334305 | CMS |
| Novo Nordisk Inc | $18.36 | 04/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188975649 | CMS |
| Novo Nordisk Inc | $28.56 | 04/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188931724 | CMS |
| Novo Nordisk Inc | $20.47 | 05/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188707928 | CMS |
| Novo Nordisk Inc | $21.74 | 07/31/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188530702 | CMS |
| Novo Nordisk Inc | $21.06 | 11/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189062485 | CMS |
| Tandem Diabetes Care, Inc. | $27.93 | 05/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1241303343 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2024, 2025
- Source files
- Dataset page · Bulk file · PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.